enterprisetherapeutics.com Open in urlscan Pro
5.101.149.139  Public Scan

Form analysis
0 forms found in the DOM

Text Content

We are developing new medicines
to treat patients with these diseases
leading to healthier and longer lives

We are developing new medicines
to treat patients with these diseases
leading to healthier and longer lives

 * Twitter
 * LinkedIn
 * Mail

Phone: +44 (0)1273 234667 | Email: info@enterprisetherapeutics.com
 * Home
 * About Us
   * Leadership Team
   * Board
   * Advisory Board
 * Scientific Strategy
 * Pipeline
 * Publications, News & Events
 * Contact Us
 * Search
 * Menu Menu



More than 700 million
people globally suffer from
a respiratory disease

Respiratory diseases such as
cystic fibrosis, asthma and COPD
cause millions of deaths per year





More than 700 million
people globally suffer from
a respiratory disease

Respiratory diseases such as
cystic fibrosis, asthma and COPD
cause millions of deaths per year






ENTERPRISE THERAPEUTICS



Enterprise Therapeutics is a drug discovery company dedicated to the research
and development of novel therapies for the treatment of respiratory diseases.

In diseases such as cystic fibrosis, asthma and COPD the lungs become congested
with mucus leading to difficulty in breathing. New disease modifying therapies
that target the underlying mechanisms of mucus congestion will reduce the
frequency of lung infections and improve patient quality of life.


Learn more...


LATEST PUBLICATIONS, NEWS & EVENTS





ENTERPRISE THERAPEUTICS APPOINTS DR NIYATI PRASAD AS CHIEF MEDICAL OFFICER

Dr Prasad will lead Enterprise’s development strategy to support…
February 8, 2022/by admin



ENTERPRISE THERAPEUTICS DOSES FIRST SUBJECTS IN PHASE I TRIAL FOR NOVEL CYSTIC
FIBROSIS THERAPY ETD001

ETD001 is a novel inhaled, long-acting ENaC inhibitor
Therapy…
June 14, 2021/by admin



ENTERPRISE THERAPEUTICS’ FIRST-IN-CLASS TMEM16A POTENTIATOR PROGRAM FOR
TREATMENT OF CYSTIC FIBROSIS AND OTHER RESPIRATORY DISEASES ACQUIRED BY ROCHE

Enterprise’s novel TMEM16A potentiator portfolio includes…
October 7, 2020/by admin


MEET THE TEAMS




LEADERSHIP TEAM

Impressive drug discovery and development team with extensive experience in
delivering novel and effective treatments for respiratory diseases in pharma and
biotech settings.

Learn more




BOARD

International blend of leading corporate (Novartis Venture Fund) and more
traditional venture investors (Versant, Forbion, IP Group, Epidarex) bringing
individuals with a fantastic track record in Pharma and building exceptional
Biotech companies.

Learn more




ADVISORY BOARD

We work closely with leading scientific experts and world-renowned physicians
involved in the development of new treatments for respiratory diseases.

Learn more




ENTERPRISE THERAPEUTICS

Enterprise Therapeutics is a drug discovery company dedicated to the research
and development of novel therapies for the treatment of respiratory diseases.
The company is based in the UK with offices at the Sussex Innovation Centre.


LATEST NEWS

 * Enterprise Therapeutics appoints Dr Niyati Prasad as Chief Medical
   OfficerFebruary 8, 2022 - 8:00 am
 * Enterprise Therapeutics doses first subjects in Phase I trial for novel
   cystic fibrosis therapy ETD001June 14, 2021 - 9:00 am
 * Enterprise Therapeutics’ First-in-Class TMEM16A potentiator program for
   treatment of cystic fibrosis and other respiratory diseases acquired by
   RocheOctober 7, 2020 - 7:02 am
 * Enterprise Therapeutics doses first subjects in Phase 1 trial for
   First-in-Class cystic fibrosis therapy ETD002August 17, 2020 - 9:00 am


FOLLOW US ON TWITTER

Enterprise Therapeutics@EnterpriseThera·
19 Oct


A huge congratulations to @EmilysEntourage on raising $975,669 (and counting) at
its annual gala this year!

We are proud to have returned as sponsors, to support the charity in its mission
to find a cure for all with #CysticFibrosis.

Learn more: https://bit.ly/3eJdH6M

Reply on Twitter 1582700842352009220Retweet on Twitter 1582700842352009220Like
on Twitter 15827008423520092201Follow us on Twitter 1582700842352009220


CONTACT US

Sussex Innovation Centre,
University of Sussex,
Science Park Square,
Falmer, Brighton, BN1 9SB


info@enterprisetherapeutics.com
+44 (0)1273 234667

Privacy & Cookie Policy





© Copyright - Enterprise Therapeutics - powered by Enfold WordPress Theme
Scroll to top

We use cookies on our website to give you the most relevant experience by
remembering your preferences and repeat visits. By clicking “Accept”, you
consent to the use of ALL the cookies. To choose which cookies you would like to
accept please change your Cookie Settings
Cookie SettingsPrivacy and Cookie PolicyACCEPT ALL
Manage Cookies
Close

PRIVACY OVERVIEW

This website uses cookies to improve your experience while you navigate through
the website. Out of these, the cookies that are categorized as necessary are
stored on your browser as they are essential for the working of basic
functionalities of the ...
Necessary
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly.
These cookies ensure basic functionalities and security features of the website,
anonymously.

CookieDurationDescriptioncookielawinfo-checbox-analytics11 monthsThis cookie is
set by GDPR Cookie Consent plugin. The cookie is used to store the user consent
for the cookies in the category "Analytics".cookielawinfo-checbox-functional11
monthsThe cookie is set by GDPR cookie consent to record the user consent for
the cookies in the category "Functional".cookielawinfo-checbox-others11
monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to
store the user consent for the cookies in the category
"Other.cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR
Cookie Consent plugin. The cookies is used to store the user consent for the
cookies in the category "Necessary".cookielawinfo-checkbox-performance11
monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to
store the user consent for the cookies in the category
"Performance".local_storage_support_testpersistentThe cookie is used in context
with the local-storage function in the browser. This function allows the website
to load faster by pre-loading certain
procedures.PHPSESSIDSessionrc::apersistentThis cookie is used to distinguish
between humans and bots. This is beneficial for the website, in order to make
valid reports on the use of their website.rc::cSessionThis cookie is used to
distinguish between humans and bots.viewed_cookie_policy11 monthsThe cookie is
set by the GDPR Cookie Consent plugin and is used to store whether or not user
has consented to the use of cookies. It does not store any personal data.

Functional
Functional
Functional cookies help to perform certain functionalities like sharing the
content of the website on social media platforms, collect feedbacks, and other
third-party features.

CookieDurationDescription__widgetsettingspersistentThis cookie is set by Twitter
- The cookie allows the visitor to share content from the website on to their
Twitter profile.

Statistics
Statistics
Statistics or analytical cookies are used to understand how visitors interact
with the website. These cookies help provide information on metrics the number
of visitors, bounce rate, traffic source, etc.

CookieDurationDescriptioncollect google-analytics.comSessionUsed to sen d data
to Google Analytics about the visitor's device and behavior. Tracks the visitor
across devices and marketing channels._ga enterprisetherapeutics.com2
yearsRegisters a unique ID that is used to generate statistical data on how the
visitor uses the website._gat enterprisetherapeutics.com1 dayUsed by Google
Analytics to throttle request rate_gid enterprisetherapeutics.com1 dayRegisters
a unique ID that is used to generate statistical data on how the visitor uses
the website.

Marketing
Marketing
Marketing or advertisement cookies are used to provide visitors with relevant
ads and marketing campaigns. These cookies track visitors across websites and
collect information to provide customized ads.

CookieDurationDescriptionIDE doubleclick.net1 yearUsed by Google DoubleClick to
register and report the website user's actions after viewing or clicking one of
the advertiser's ads with the purpose of measuring the efficacy of an ad and to
present targeted ads to the user.test_cookie doubleclick.net1 dayUsed to check
if the user's browser supports cookies.VISITOR_INFO1_LIVE179 daysTries to
estimate the users' bandwidth on pages with integrated You Tube
videos.YSCSessionRegisters a unique ID to keep statistics of what videos from
You Tube the user has seen.yt-remote-cast-installedSessionStores the user's
video player preferences using embedded You Tube
videoyt-remote-connected-devicespersistentStores the user's video player
preferences using embedded You Tube videoyt-remote-device-idpersistentStores the
user's video player preferences using embedded You Tube
videoyt-remote-fast-check-periodSessionStores the user's video player
preferences using embedded You Tube videoyt-remote-session-appSessionStores the
user's video player preferences using embedded You Tube
videoyt-remote-session-nameSessionStores the user's video player preferences
using embedded You Tube videoyt.innertube::nextIdpersistentRegisters a unique ID
to keep statistics of what videos from You Tube the user has
seen.yt.innertube::requestspersistentRegisters a unique ID to keep statistics of
what videos from You Tube the user has seen.

SAVE & ACCEPT
Powered by